Age, statin use, and the risk for incident Parkinson disease

Archives of Neurology

Volumn 69, Issue 10, 2012, Pages 1381-

  Andrade, Chittaranjan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGING; DISEASE COURSE; DRUG EFFICACY; DRUG USE; HUMAN; LETTER; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT DURATION; TREATMENT OUTCOME;

FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PARKINSON DISEASE;

EID: 84867369703     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2012.1132     Document Type: Letter

References (1)

1. Gao X, Simon KC, Schwarzschild MA, Ascherio A. Prospective study of statin use and risk of Parkinson disease. Arch Neurol. 2012;69(3):380-384.